Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Update

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRAGet Free Report) saw a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 3,660 shares, an increase of 3,752.6% from the February 12th total of 95 shares. Currently, 1.5% of the company’s stock are short sold. Based on an average daily volume of 3,171 shares, the days-to-cover ratio is presently 1.2 days. Based on an average daily volume of 3,171 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.5% of the company’s stock are short sold.

Bitwise MARA Option Income Strategy ETF Price Performance

IMRA stock traded down $0.12 during trading hours on Thursday, reaching $13.68. 1,087 shares of the stock were exchanged, compared to its average volume of 5,843. The firm’s 50-day moving average is $15.04 and its 200-day moving average is $24.37. Bitwise MARA Option Income Strategy ETF has a 12 month low of $11.99 and a 12 month high of $60.73. The company has a market cap of $3.28 million, a price-to-earnings ratio of 273.60 and a beta of -6.67.

Bitwise MARA Option Income Strategy ETF Company Profile

(Get Free Report)

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2?related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.

Further Reading

Receive News & Ratings for Bitwise MARA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bitwise MARA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.